Trans-Pacific Partnership

A look at what's being said about TPP-11's prospects.

President Trump is set to meet with key trading partners in Asia without a coherent and effective strategy to achieve positive outcomes for the U.S., multiple sources and trade analysts have told Inside U.S. Trade -- adding that U.S. trade officials are not pushing China to make changes to its industrial policy in a bid to build a narrative that supports the case for tougher action in the future.

"Is it worthwhile spending hundreds of hours and efforts to try and reach a deal which may be politically spiky at home in our countries, and then finally it doesn't go through – and what was this for?"

PIIE: Direct economic losses for the U.S. “would be modest at first, but greater costs would follow as large economies begin to shape regional rules.”

Two AEI scholars say TPP can “serve as the baseline for negotiations” on agriculture, including beef, pork and dairy exports.

The second round of North American Free Trade Agreement renegotiation talks is expected to provide opportunities for Mexico and Canada to respond to the robust e-commerce chapter the U.S. pitched during the inaugural round, sources told Inside U.S. Trade.

“We’re all open to evaluating what we can do and what viable alternatives there may be,” said Peru’s deputy trade minister.

The issue of data exclusivity for biologic drugs could spark less controversy in a retooled NAFTA than it did when the Obama administration presented a Trans-Pacific Partnership to Congress that did not feature a 12-year exclusivity requirement, sources tell Inside U.S. Trade – though the issue is far from resolved and could still be a major sticking point for some in Congress and in the pharmaceutical industry.

“Six months ago, no one thought TPP11 could happen but we've got this far.”